OVERVIEW

Overview of Xylazine is organized by UK HealthCare CECentral.

Start Date: Feb 15, 2024
End Date: Feb 14, 2027

Description:
Xylazine is a non-opioid used as a sedative for animals and is gaining emergence across the USA.  Xylazine is most often found mixed into opioids like fentanyl to extend the effects. Many individuals including healthcare professionals are not familiar with this substance and its adverse effects. This presentation will review the best practices in identifying people using xylazine, providing access to care and treatment, and effective policies that will address the issue.

Objectives:
Upon completion of this activity, participants will be able to:
Discuss an overview of xylazine, including its history, structure, pharmacology, clinical effects, emerging epidemiology, and ethnographic research with individuals using xylazine
• Discuss xylazine's contribution to overdoses, intervention strategies, and harm reduction strategies for xylazine use
• Discuss toxicology testing and drug checking strategies for xylazine Discuss wounds due to xylazine use
• Discuss xylazine withdrawal and its management strategies

Credits

Accreditation:
In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME:
This enduring material is designated for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
This training has been approved by the KBML as meeting the statutory requirements of HB1. 0623-H1.5-UKHC/Jun23

IPE Competencies:
Values/Ethics for Interprofessional Practice
• Roles/ Responsibilities
• Interprofessional Communication
• Teams and Teamwork

CPE:
This knowledge-based activity will award 1.25 contact hours (0.125 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

ASWB ACE:
As a Jointly Accredited Organization, UK HealthCare CECentral is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. UK HealthCare CECentral maintains responsibility for this course. Social workers completing this course receive 1.25 clinical continuing education credits.

CNE:
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.25 nursing contact hours.

  • 1.25 AMA PRA Category 1 Credits™
  • 1.25 CEUs
  • 1.25 CME
  • 1.25 CPE
  • 1.25 Contact Hours
  • TARGET AUDIENCE

    PhysicianPharmacistPhysician AssistantNursesSocial WorkersAddictions ProfessionalsNurse Practitioners

    SPECIALITIES

    PharmacologyAddiction Medicine

    RELATED ONLINE COURSES